MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202617078517 A) filed by Ltt Bio-Pharma Co. , Ltd.; and Musashino University on June 25, 2026, for Prophylactic And Therapeutic Agent For Diseases Caused By Type I Allergic Reaction Accompanying Administration Of Anticancer Agent.
Inventors include Mizushima, Tohru; Tanji, Hayato; Ogihara, Kota; Ishikawa, Tomohiro; Tsukiyama, Naohiro; and Tanaka, Ken-Ichiro.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The present invention addresses the problem of providing a prophylactic and therapeutic agent for diseases caused by a type I allergic reaction accompanying administration of a platinum preparation and/or a taxane-based anticancer agent. The present invention relates to a pharmaceutical composition for treating or preventing diseases caused by a type I allergic reaction accompanying administration of a platinum preparation and/or a taxane-based anticancer agent, the pharmaceutical composition containing a lecithinized superoxide dismutase.
Disclaimer: Curated by HT Syndication.
